Gender-sensitive enhancement of commonweight loss strategies for overweight andobesity: a personalized smartphone app - I-GENDO

Otto-Friedrich-Universität Bamberg0 个研究点目标入组 213 人开始时间: 2019年5月3日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Obesity class I or II with subjectively experienced weight-related impairment and a current will to lose weight.
•2. Overweight (i.e. BMI between 25 and 29.9 kg/m²) with weight-related health problems and/or visceral adipose tissue and/or high psycosocial weight-related distress with a current will to lose weight.

•1. Obesity Class III (i.e. BMI >39.9 kg/m²).
•2. Current (or within the last 12 months) involvement in a structured weight loss intervention.
•3. Insulin-dependent type 1 diabetes.
•4. Previous or intended bariatric surgery.
•5. Current psychotherapeutic treatment of weight-related health problems.
•6. Weight-enhancing drugs.
•7. Drugs which promote weight-loss (e.g. anti-obesity drugs).
•8. Weight-enhancing health problems which are not yet treated.
•9. Cancerous disease within the last five years.
•10. Current substance-use disorders, depression, psychosis, suicidal tendency or pregnancy.
•11. Severe cognitive impairments.
•12. Insufficient knowledge of the german language.
•13. Binge-Eating Disorder or Bulimia nervosa.

发起方

Otto-Friedrich-Universität Bamberg